Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2022-01-05 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
康泰医学系统（秦皇岛）股份有限公司创业板向不特定对象发行可转换公司债券募集说明书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "募集说明书（修订稿）" which translates to "Offering Circular (Revised)" or "Prospectus (Revised)" for a convertible bond issuance by 康泰医学系统（秦皇岛）股份有限公司. It contains detailed information about the issuance of convertible bonds, compliance with regulatory requirements, credit rating, risk factors, profit distribution policies, and other disclosures related to the bond offering. The document is lengthy (15,000 characters) and contains substantive financial and operational information related to the capital raising activity. It is not an announcement of a report, nor a transcript, nor a general regulatory filing. It is a detailed disclosure document related to capital raising through convertible bonds. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-01-05 Chinese
公司与中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司申请向不特定对象发行可转换公司债券的审核中心意见落实函的回复
Capital/Financing Update Classification · 95% confidence The document is a detailed reply from a company (康泰医学系统（秦皇岛）股份有限公司) and its sponsor to a regulatory authority (Shenzhen Stock Exchange) regarding the application for issuance of convertible bonds to unspecified investors. It discusses the company's production capacity expansion plans, market analysis, sales data, risk disclosures, and responses to regulatory queries. The content is focused on the company's capital raising activity through convertible bonds and related disclosures. It is not a full annual or interim financial report, nor an earnings release or management discussion. It is not a simple announcement or certification but a substantive regulatory response related to capital financing. Therefore, the document fits best under Capital/Financing Update (CAP).
2022-01-05 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转债并在创业板上市之发行保荐书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行保荐书" (Securities Issuance Sponsorship Letter) issued by 中信建投证券股份有限公司 regarding 康泰医学系统（秦皇岛）股份有限公司's issuance of convertible bonds to unspecified investors and listing on the Growth Enterprise Market (创业板). It contains detailed information about the issuance, the sponsoring institution's due diligence, legal compliance, internal review procedures, financial data of the issuer, and regulatory compliance statements. The document is lengthy (15,000 characters) and contains substantive content related to the issuance process, legal and regulatory compliance, and financial data. It is not a brief announcement or a certification letter but a comprehensive sponsorship report related to a capital market transaction. This type of document corresponds to a Capital/Financing Update (CAP) as it provides detailed updates on the company's fundraising activity and capital structure changes through convertible bond issuance.
2022-01-05 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券之补充法律意见书（二）
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm (北京市长安律师事务所) regarding the issuance of convertible bonds by 康泰医学系统（秦皇岛）股份有限公司. It is titled as a "Supplementary Legal Opinion Letter (二)" and addresses legal matters related to the issuance, including compliance with laws and regulations, land use rights, and project progress. The document is not a financial report, earnings release, or management discussion. It is a legal advisory document related to a capital market transaction (issuance of convertible bonds). It does not contain financial statements or audit results, nor is it a regulatory announcement or a report publication announcement. Given the nature of the document as a legal opinion on a financing activity, the most appropriate classification is "Capital/Financing Update (CAP)" which covers updates on company fundraising and financing activities.
2022-01-05 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转债并在创业板上市之上市保荐书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to a "Securities Listing Sponsorship Letter" issued by a sponsoring institution (中信建投证券股份有限公司) for 康泰医学系统（秦皇岛）股份有限公司 regarding the issuance of convertible bonds and listing on the Growth Enterprise Market (创业板). The content includes detailed company background, business overview, financial data, risk factors, and regulatory compliance statements. It is a comprehensive document related to the company's capital market activity, specifically the issuance and listing of convertible bonds. This type of document is a capital/financing update related to fundraising and listing activities rather than a full annual report, earnings release, or other categories. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed financial and business information support this classification with high confidence.
2022-01-05 Chinese
关于公司申请向不特定对象发行可转换公司债券的审核中心意见落实函回复的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding its application to issue convertible bonds to unspecified investors. It references regulatory review and approval processes by the Shenzhen Stock Exchange and the China Securities Regulatory Commission. The content focuses on the company's response to a regulatory inquiry and the status of the approval process. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (737 characters) and serves as an update on a financing activity rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-01-05 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.